Skip to content
Greencross Virtual Conference
Seminar Quiz
*
1.
Please complete the below:
(Required.)
First Name
Surname
Company Name
Post Code
Email Address
*
2.
Please tick here if you would like to receive further communication from Boehringer Ingelheim of a technical and marketing nature. You can of course unsubscribe at any time and please be assured that Boehringer Ingelheim Pty Ltd is bound by the Australian Privacy Principles and adheres to these Principles. You can view our Privacy Policy at
https://www.boehringer-ingelheim.com.au/data-privacy
.
(Required.)
Yes
No
*
3.
What are the benefits of mucosal (intranasal or oral) vaccination against Bordetella bronchiseptica?
(Required.)
Local mucosal immunity (IgA) and systemic immunity (IgG)
Only one dose required in the primary course
Excellent efficacy, with up to 100% reduction in clinical disease
No interference from maternally derived antibodies (MDA) interference
All of the above
*
4.
Which canine vaccine from Boehringer Ingelheim provides robust protection against Bordetella bronchiseptica, with simple, no-fuss administration to reduce stress for both the dog and owner?
(Required.)
Protech® Bronchi-Shield® Oral
Protech® Bronchi-Shield® III
Protech® Pi2
*
5.
Which once-a-month, easy-to-give, tasty chew is the only product in Australia registered to protect against the five major parasite groups (fleas, ticks, mites, heartworm, intestinal worms) in dogs?
(Required.)